F1TITLE IIIAUTHORISATION AND SUPERVISION OF VETERINARY MEDICINAL PRODUCTS
Annotations:
Amendments (Textual)
F1Chapter 1Submission and examination of applications — Authorisations
F1Article 30
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F1Article 31
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F1Article 32
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F1Article 33
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F1Article 34
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F1Article 35
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F1Article 36
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F1Article 37
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F1Article 38
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F1Article 39
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F1Article 40
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Regulation revoked insofar as it applies to medicinal products for veterinary use (31.12.2020) by The Veterinary Medicines and Animals and Animal Products (Examination of Residues and Maximum Residue Limits) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/676), regs. 1(2)(b), 5; 2020 c. 1, Sch. 5 para. 1(1)
Regulation revoked insofar as it applies to medicinal products for human use (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), Sch. 9 para. 1(h) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)